Literature DB >> 21982360

Skeletal muscle microcirculatory abnormalities are associated with exercise intolerance, ventilatory inefficiency, and impaired autonomic control in heart failure.

Christos Manetos1, Stavros Dimopoulos, Georgios Tzanis, Stella Vakrou, Athanasios Tasoulis, Chris Kapelios, Varvara Agapitou, Argirios Ntalianis, John Terrovitis, Serafim Nanas.   

Abstract

BACKGROUND: Several skeletal muscle abnormalities have been identified in patients with chronic heart failure (CHF), including endothelial dysfunction. We hypothesized that skeletal muscle microcirculation, assessed by near-infrared spectroscopy (NIRS), is impaired in CHF patients and is associated with disease severity.
METHODS: Eighty-three stable patients with mild-moderate CHF (72 males, mean age 54 ± 14 years, body mass index 26.7 ± 3.4 kg/m(2)) and 8 healthy subjects, matched for age, gender and body mass index, underwent NIRS with the vascular occlusion technique and cardiopulmonary exercise testing (CPET) evaluation on the same day. Tissue oxygen saturation (StO(2), %), defined as the percentage of hemoglobin saturation in the microvasculature compartments, was measured in the thenar muscle by NIRS before, during and after 3-minute occlusion of the brachial artery. Measurements included StO(2), oxygen consumption rate (OCR, %/min) and reperfusion rate (RR, %/min). All subjects underwent a symptom-limited CPET on a cycle ergometer. Measurements included VO(2) at peak exercise (VO(2)peak, ml/kg/min) and anaerobic threshold (VO(2)AT, ml/kg/min), VE/VCO(2) slope, chronotropic reserve (CR, %) and heart rate recovery (HRR(1), bpm).
RESULTS: CHF patients had significantly lower StO(2) (75 ± 8.2 vs 80.3 ± 6, p < 0.05), lower OCR (32.3 ± 10.4 vs 37.7 ± 5.5, p < 0.05) and lower RR (10 ± 2.8 vs 15.7 ± 6.3, p < 0.05) compared with healthy controls. CHF patients with RR ≥9.5 had a significantly greater VO(2)peak (p < 0.001), VO(2)AT (p < 0.01), CR (p = 0.01) and HRR(1) (p = 0.01), and lower VE/VCO(2) slope (p = 0.001), compared to those with RR <9.5. In a multivariate analysis, RR was identified as an independent predictor of VO(2)peak, VE/VCO(2) slope and HRR(1).
CONCLUSIONS: Peripheral muscle microcirculation, as assessed by NIRS, is significantly impaired in CHF patients and is associated with disease severity. Copyright Â
© 2011 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21982360     DOI: 10.1016/j.healun.2011.08.020

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  10 in total

Review 1.  Protocol for exercise hemodynamic assessment: performing an invasive cardiopulmonary exercise test in clinical practice.

Authors:  Natalia C Berry; Agarwal Manyoo; William M Oldham; Thomas E Stephens; Ronald H Goldstein; Aaron B Waxman; Julie A Tracy; Peter J Leary; Jane A Leopold; Scott Kinlay; Alexander R Opotowsky; David M Systrom; Bradley A Maron
Journal:  Pulm Circ       Date:  2015-12       Impact factor: 3.017

Review 2.  The impact of different forms of exercise on circulating endothelial progenitor cells in cardiovascular and metabolic disease.

Authors:  Panagiotis Ferentinos; Costas Tsakirides; Michelle Swainson; Adam Davison; Marrissa Martyn-St James; Theocharis Ispoglou
Journal:  Eur J Appl Physiol       Date:  2022-01-12       Impact factor: 3.078

3.  A Cardiac Rehabilitation Program Increases the Acute Response of Endothelial Progenitor Cells to Maximal Exercise in Heart Failure Patients.

Authors:  Christos Kourek; Stavros Dimopoulos; Manal Alshamari; Virginia Zouganeli; Katherina Psarra; Georgios Mitsiou; Argyrios Ntalianis; Theodoros Pittaras; Serafim Nanas; Eleftherios Karatzanos
Journal:  Acta Cardiol Sin       Date:  2022-07       Impact factor: 1.800

Review 4.  Exercise intolerance in chronic heart failure: the role of cortisol and the catabolic state.

Authors:  Georgios Tzanis; Stavros Dimopoulos; Varvara Agapitou; Serafim Nanas
Journal:  Curr Heart Fail Rep       Date:  2014-03

Review 5.  Therapeutic Targets for the Multi-system Pathophysiology of Heart Failure: Exercise Training.

Authors:  Erik H Van Iterson; Thomas P Olson
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-10-09

6.  Changes in skeletal muscle microcirculation after a hemodialysis session correlates with adequacy of dialysis.

Authors:  Chrysoula Pipili; Eirini Grapsa; Elli-Sophia Tripodaki; Sophia Ioannidou; Christos Manetos; Maria Parisi; Serafim Nanas
Journal:  Int J Nephrol Renovasc Dis       Date:  2015-06-08

Review 7.  Left Ventricular Assist Device Support Complicates the Exercise Physiology of Oxygen Transport and Uptake in Heart Failure.

Authors:  Erik H Van Iterson
Journal:  Card Fail Rev       Date:  2019-11-04

8.  The acute and long-term effects of a cardiac rehabilitation program on endothelial progenitor cells in chronic heart failure patients: Comparing two different exercise training protocols.

Authors:  Christos Kourek; Manal Alshamari; Georgios Mitsiou; Katherina Psarra; Dimitrios Delis; Vasiliki Linardatou; Theodoros Pittaras; Argyrios Ntalianis; Costas Papadopoulos; Niki Panagopoulou; Ioannis Vasileiadis; Serafim Nanas; Eleftherios Karatzanos
Journal:  Int J Cardiol Heart Vasc       Date:  2020-12-24

9.  Relationship between skeletal muscle mass and cardiac function during exercise in community-dwelling older adults.

Authors:  Masamitsu Sugie; Kazumasa Harada; Tetsuya Takahashi; Marina Nara; Joji Ishikawa; Teruyuki Koyama; Hunkyung Kim; Jun Tanaka; Hajime Fujimoto; Shuichi Obuchi; Stephan von Haehling; Syunei Kyo; Hideki Ito
Journal:  ESC Heart Fail       Date:  2017-04-10

10.  Muscle-Skeletal Abnormalities and Muscle Oxygenation during Isokinetic Strength Exercise in Heart Failure with Preserved Ejection Fraction Phenotype: A Cross-Sectional Study.

Authors:  Amanda Vale-Lira; Natália Turri-Silva; Kenneth Verboven; João Luiz Quagliotti Durigan; Alexandra Corrêa G B de Lima; Martim Bottaro; Gaspar R Chiappa; Dominique Hansen; Gerson Cipriano
Journal:  Int J Environ Res Public Health       Date:  2022-01-09       Impact factor: 3.390

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.